This grant, offered by the National Cancer Institute (NCI), aims to advance and validate innovative technologies addressing pre-analytical variations in biospecimen collection, processing, and storage. Its core purpose is to maximize biospecimen quality and utility for downstream molecular analyses in cancer research. The funding supports the development of new tools, devices, and methods for assessing sample quality, preserving integrity, and establishing verification criteria. This R33 mechanism requires established proof-of-principle and preliminary data for the proposed technology. Projects focusing on novel biological questions using established technologies are not appropriate for this solicitation.
Opportunity ID: 135257
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-12-005 |
| Funding Opportunity Title: | Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 21, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 18, 2012 |
| Current Closing Date for Applications: | Sep 18, 2012 |
| Archive Date: | Oct 19, 2012 |
| Estimated Total Program Funding: | $700,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal governments (Federally recognized) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Special district governments City or township governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing technically innovative feasibility studies focused on the advanced development and validation of cancer-relevant technologies that address issues related to pre-analytical variations in the collection, processing, handling, and storage of biospecimens or their derivatives. The overall goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or their derived samples for downstream molecular analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. This FOA solicits R33 applications; this mechanism is suitable for projects where proof-of-principle of the proposed technology or methodology has already been established and supportive preliminary data are available. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation as non-responsive and will not be reviewed. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-005.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00089371 | Jan 23, 2012 | Sep 18, 2012 | View |
Package 1
Mandatory forms
135257 RR_SF424_1_2-1.2.pdf
135257 PerformanceSite_1_4-1.4.pdf
135257 RR_OtherProjectInfo_1_3-1.3.pdf
135257 RR_KeyPersonExpanded_1_2-1.2.pdf
135257 RR_Budget-1.1.pdf
135257 PHS398_CoverPageSupplement_1_4-1.4.pdf
135257 PHS398_ResearchPlan_1_3-1.3.pdf
135257 PHS398_Checklist_1_3-1.3.pdf
Optional forms
135257 RR_SubawardBudget30-1.2.pdf
135257 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
